Advances in oligonucleotide drug delivery

TC Roberts, R Langer, MJA Wood - Nature reviews Drug discovery, 2020 - nature.com
Oligonucleotides can be used to modulate gene expression via a range of processes
including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation …

The wide and growing range of lamin B-related diseases: from laminopathies to cancer

C Evangelisti, I Rusciano, S Mongiorgi… - Cellular and Molecular …, 2022 - Springer
B-type lamins are fundamental components of the nuclear lamina, a complex structure that
acts as a scaffold for organization and function of the nucleus. Lamin B1 and B2, the most …

Lamin B1 as a key modulator of the developing and aging brain

FD Koufi, I Neri, G Ramazzotti, I Rusciano… - Frontiers in Cellular …, 2023 - frontiersin.org
Lamin B1 is an essential protein of the nuclear lamina that plays a crucial role in nuclear
function and organization. It has been demonstrated that lamin B1 is essential for …

[HTML][HTML] Allele-specific genome targeting in the development of precision medicine

J Wu, B Tang, Y Tang - Theranostics, 2020 - ncbi.nlm.nih.gov
The CRISPR-based genome editing holds immense potential to fix disease-causing
mutations, however, must also handle substantial natural genetic variations between …

Nanocarriers for Delivery of Oligonucleotides to the CNS

D Male, R Gromnicova - International journal of molecular sciences, 2022 - mdpi.com
Nanoparticles with oligonucleotides bound to the outside or incorporated into the matrix can
be used for gene editing or to modulate gene expression in the CNS. These nanocarriers …

Gene therapy for CNS disorders: modalities, delivery and translational challenges

J Gao, S Gunasekar, Z Xia, K Shalin, C Jiang… - Nature Reviews …, 2024 - nature.com
Gene therapy is emerging as a powerful tool to modulate abnormal gene expression, a
hallmark of most CNS disorders. The transformative potentials of recently approved gene …

RNA therapeutics for neurological diseases

I Brentari, M Zadorozhna, MA Denti… - British Medical …, 2023 - academic.oup.com
Introduction Ribonucleic acid (RNA) therapeutics are a new class of drugs whose
importance is highlighted by the growing number of molecules in the clinic. Sources of data …

Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes

S Ratti, I Rusciano, S Mongiorgi… - Cellular and Molecular …, 2021 - Springer
Autosomal-dominant leukodystrophy (ADLD) is a rare fatal neurodegenerative disorder with
overexpression of the nuclear lamina component, Lamin B1 due to LMNB1 gene duplication …

Identification and optimization of a minor allele-specific siRNA to prevent PNPLA3 I148M-driven nonalcoholic fatty liver disease

JK Murray, J Long, L Liu, S Singh, D Pruitt… - nucleic acid …, 2021 - liebertpub.com
Human genome wide association studies confirm the association of the rs738409 single
nucleotide polymorphism (SNP) in the gene encoding protein patatin like phospholipase …

[HTML][HTML] Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing

S Maruelli, R Besio, J Rousseau, N Garibaldi… - Matrix Biology Plus, 2020 - Elsevier
Classical osteogenesis imperfecta (OI) is an inherited rare brittle bone disease caused by
dominant mutations in the COL1A1 or COL1A2 genes, encoding for the α chains of collagen …